Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07465315
Starting soon Phase 2/3

Behavioural Intervention to Decrease Exposure to Emerging Chemical Pollutants

NCT07465315 · tracked via the Priya Life Science Spain tracker
Phase
Phase 2/3
Started
2026-05
Last updated
2026-03-16

Condition(s) studied

Environmental Exposure

Investigational drug(s) / intervention(s)

Guidelines from the public healthcare systemINPOL healthy lifestyle informative guidelines

Guidelines from the public healthcare system: Healthy lifestyle guidelines from the public healthcare system, supported by short talks

INPOL healthy lifestyle informative guidelines: Informative guidelines focused on how to decrease environmental chemical pollutant exposure, supported by short talks and social network interaction.

Study summary

The purpose of this study is to evaluate the effectiveness of a behavioural intervention designed to reduce exposure to environmental chemical pollutants among adults in Spain.

Eligibility

Sex
ALL
Min age
30 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria for the Screening phase: * Not planning to change residence within one year after recruitment * Spanish fluency * Living independently in the community * WhatsApp user * Age 30-60 years * Providing signed informed consent Exclusion Criteria for the Screening phase: * Unable to provide any of the required biological samples * Suffering any chronic condition that substantially hinders adherence to the trial protocol and/or affects pollutant analyses * Inability to understand the informed consent, questionnaires, or intervention * Already participating in another intervention trial at the time of recruitment * Pregnancy or lactation * Inability to communicate with the research team and/or to attend the follow-up visits Inclusion Criteria for the Intervention Phase: * Not planning to change residence within one year after recruitment * Spanish fluency * Living independently in the community * WhatsApp user * Age 30-60 years * Providing signed informed consent * Participant of the Screening phase Exclusion Criteria for the Intervention Phase: * Unable to provide any of the required biological samples * Suffering from any chronic condition that substantially hinders adherence to the trial protocol and/or affects pollutant analyses * Inability to understand the informed consent, questionnaires, or intervention * Already participating in another intervention trial at the time of recruitment * Pregnancy or lactation * Inability to communicate with the research team and/or attend follow-up visits

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Hospital Universitario Clínico San Cecilio Granada Granada
Hospital Comarcal Santa Ana Motril Granada
Hospital Universitario de Fuenlabrada Fuenlabrada Madrid
Hospital Universitario 12 de Octubre Madrid Madrid
Clínica de neurociencias Imbrain Melilla Melilla

More Universidad de Granada trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07465315 on ClinicalTrials.gov ↗ ← All trials in Spain